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Tachyplesin I, a cationic heptadecapeptide amide containing two disulfide bonds isolated from hemocytes of Tuchypleus 
tridentutus, which binds to lipopolysaccharide, was synthesized by a solid-phase procedure. Reduction and oxidation of 
the deprotected peptide amide yielded an identical pcptide to native tachyplesin I in terms of chemical and biological 
properties. Tachyplesin I was found to bind to alkylphosphorylcholine accompanied by perturbation of its tyrosyl and 
tryptophyl residues but bound only weakly to N-acetyl-D-glucosamine t tramer. 
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1. INTRODUCTION 
Tachyplesin I, a cationic heptadecapeptide 
amide (fig.l), isolated from the hemocyte mem- 
brane of Japanese horseshoe crab (Tachypleus 
tridentatus), is able to bind to lipopolysaccharide 
(LPS) and to neutralize the Limulus factor C- 
activating activity of LPS [l]. Thus tachyplesin I
prevents initiation of an activation cascade leading 
to coagulation of the Limulus lysate [2-41. In ad- 
dition, the peptide has been found to exhibit strong 
antimicrobial activity against both Gram-positive 
and -negative bacteria [l]. The total synthesis of 
this peptide and its variants appears to be very pro- 
mising for elucidation of the structure-function 
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Abbreviations: Boc, t-butoxycarbonyl; Pam, phenylacetamido- 
methyl; DMF, dimethylformamide; LPS, lipopolysaccharide; 
LPC, laurylphosphorylcholine; (GlcNAck, N-acetyl-D-glu- 
cosamine tetramer; HPLC, high-performance liquid chroma- 
tography; all amino acids are of the L-configuration 
relationship of this functionally interesting pep- 
tide. Here, we describe the synthesis of tachyplesin 
I and compare data on its affinity for binding to 
alkylphosphorylcholine and N-acetyl-D-glucos- 
amine tetramer [(GlcNAc)s], both of which con- 
tain components involved in LPS. 
Fig. 1. Structure of tachyplesin I. 
2. EXPERIMENTAL 
2. I. Materials 
Aminomethylated (-0.7 mmol/g) copoly(styrene-divinyl- 
benzene) [lo/o]) resin (200-400 meshes) was obtained from 
Pierce. Boc-M-tosylarginyl-4-(oxymethyl)phenylacetic ac dwas 
prepared according to Tam et al. [5]. Boc-amino acids were sup- 
plied by the Peptide Institute (Osaka). Laurylphosphoryl- 
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choline (LPC) was synthesized as described by Hirt and 
Berchtold [6] and purified as in [7]. iV-Acetyl-D-glucosamine 
tetramer was a gift from Dr N. Yamasaki (Faculty of 
Agriculture, Kyushu University). Other reagents used were of 
the highest grade available. 
2.2. Protected heptadecapeptidyl-4-(oxymethyl)phenyl- 
acetamidomethyl resin 
Boc-Arg(Tos)-4-(oxymethyl)phenylacetamidomethyl (Pam) 
resin (0.284 mmol Arg/g) was prepared from the amino- 
methylated resin and Boc-Arg(Tos)-4-(oxymethyl)phenylacetic 
acid according to Mitchell et al. [8], followed by acetylation of 
the remaining amino group with acetic anhydride-pyridine 
(1:4). Successive additions of Boc-amino acids to Boc- 
Arg(Tos)-4-(oxymethyl)-Pam resin (1 .O g) along the sequence 
of tachyplesin I were conducted on a Beckman 990E peptide 
synthesizer according to the method of Wong and Merrifield [9] 
with minor modifications. The side-chain-protected amino 
acids employed were Np-tosylarginine, w-2-chlorobenzyloxy- 
carbonyllysine, S-4-methylbenzylcysteine, 0-benzyltyrosine 
and N’“-formyltryptophan. The final yield of the, protected 
heptadecapeptidyl-4-(oxymethyl)-Pam resin amounted to 
1.78 g (79% of theoretical value). 
2.3. Heptadecapeptide amide. 7HCI 
Protected heptadecapeptidyl-4-(oxymethyl)-Pam resin (1 .O g) 
was suspended in a mixture of anhydrous dimethylformamide 
(DMF) (12 ml) and methanol (IO ml), dried NH, gas being 
bubbled through the mixture at O’C until saturation. The vessel 
was tightly stoppered and allowed to stand for 3 days at room 
temperature. The filtrate from the resin was evaporated and the 
residue solidified by addition of water (392 mg). Reprecipita- 
tion with a DMF-methanol system gave a white solid (295 mg). 
The protected peptide amide (150 mg) was then treated with HF 
(8 ml) in the presence of anisole (1.2 ml) and 1,2-ethanedithiol 
(0.8 ml) at 0°C for 3 h. After removal of HF and extraction 
with ethyl acetate (three times), the peptide was dissolved in 5% 
acetic acid containing 0.1 M HCl (10 ml) and, after filtration, 
the solution was lyophilized. The peptide was chromatographed 
on a Sephadex G-10 column (2.0 x 25 cm) with 0.05 M HCl, 
the fraction containing the peptide being subsequently 
lyophilized (97 mg). 
2.4. Reduction and oxidation 
The peptide (40 mg) obtained above was dissolved in 0.05 M 
Tris-HCl (pH 8.5) (8 ml) containing 220,41 2-mercaptoethanol 
and the solution allowed to stand overnight at room 
temperature. The solution was acidified (pH 2) using 5.7 M 
HCl and passed through a Sephadex G-10 column (2.0 x 25 cm) 
with 0.05 M HCI. The fraction (12 ml) containing the peptide 
was diluted to 200 ml with water and the pH adjusted to 8.5 
with 0.5 M NaOH. The solution was left to stand uncovered in 
a 500 ml beaker at room temperature for 3 days with occasional 
gentle stirring. The solution was then concentrated to 10 ml by 
evaporation in vacua at 35°C and gel-filtered on a Sephadex 
G-10 column (2.0 x 25 cm) with 0.05 M HCI. The peptide- 
containing fraction was lyophilized (15.7 mg), followed by frac- 
tionation of the peptide by HPLC on a TSK.gel ODS-12OT col- 
umn (0.78 x 30 cm), using a solvent system comprising 0.1% 
trifluoroacetic acid (A)-acetonitrile containing 20% A (B). The 
peptide was eluted with a linear concentration gradient of B. 
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2.5. Tachyplesin assay 
Tachyplesin was assayed with respect to inhibitory activity 
towards LPS-mediated activation of Limulus factor C as in [l]. 
2.6. Spectroscopic titrations of peptides with LPC and 
(GlcNAc)d 
Difference spectra were recorded on a Hitachi 100-60 spec- 
trophotometer by , titrating synthetic peptide and native 
tachyplesin I (8.9-9.0 x low5 M) with increasing concentrations 
of LPC (0.09-2.71 mM) or (GlcNAc)d (0.15-1.82 mM) at pH 
8.0 (0.02 M Tris-HCl containing 0.1 M NaCl). 
3. RESULTS AND DISCUSSION 
Tachyplesin I has an amide group at the C- 
terminus (fig. 1). The absence of an ester-type side- 
chain-protecting group in the protected peptide 
that is linked to the supporting resin via the ester 
bond enabled us to cleave the peptide via am- 
monolysis, leaving an amide group at the C- 
terminus. As described in section 2, the protected 
heptadecapeptide amide was successfully cleaved 
from the resin. All protecting groups were then 
removed with HF. 
Fig.2 shows HPLC profiles of the crude syn- 
thetic peptide, HPLC-purified peptide, and native 
tachyplesin I. The purified synthetic peptide 
coeluted with native tachyplesin I as a single sharp 
peak and gave a single peak on HPLC using a 
hydroxyapatite column (TSK gel HA-1000) (not 
shown). The yield after reduction and oxidation 
was 12%. The amino acid composition of a 
hydroIysate (3 M mercaptoethanesulfonic acid) of 
the synthetic peptide was in accord with that of 
native tachyplesin I (theoretical values in paren- 
theses): Gly 1.1 (l), cystine 3.0 (4), Val 1.0 (l), Ile 
1.0 (l), Tyr 1.8 (2), Phe 0.9 (l), Lys 0.9 (l), Trp 0.8 
(l), Arg 5.1 (5). 
The ultraviolet absorption spectrum of the syn- 
thetic peptide with a maximum at 276 nm and 
shoulders at 281 and 289 nm was superimposed 
with that of native tachyplesin I (not shown). The 
IDso values for neutralizing 2.5 pg LPS were 1.25 
and 2.95 pg for synthetic and native tachyplesin I, 
respectively. The somewhat higher activity of the 
synthetic peptide vs the native form of tachyplesin 
I is probably due to partial adsorption of LPS-like 
material from the environment onto native 
tachyplesin. 
The interactions of the synthetic peptide and 
native tachyplesin I with LPC, an analog of 
phosphatidylcholine, were investigated by means 
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Fig.2. HPLC profiles of crude synthetic (A), purified synthetic 
(B) and native (C) tachyplesin I. TSK gel ODS 120T column 
(0.46 x 25 cm). Solvent system: 0.1% trifluoroacetic acid (A)- 
acetonitrile containing 20% A (B). Elution conducted using a 
linear concentration gradient of B, 25% for 2 min and 25-50% 
for 20 min. Flow rate, 1.0 ml/min. 
of difference spectroscopy at pH 8.0. When both 
materials were titrated with LPC, identical dif- 
ference spectra were obtained (fig.3 for the syn- 
thetic peptide). The inset to fig.3 shows a plot of 
the difference molar absorption coefficients at 
285 nm vs LPC concentrations. The biphasic titra- 
tion curve could be ascribed to a critical micellar 
concentration (0.6-0.7 mM) for LPC [7]. The in- 
teractions differ below and above the critical 
micellar concentration. The dissociation constants 
for binding to LPC in the monomeric dispersed 
state were computed to be 4.4-4.6 x 10e4 M for 
the synthetic and native peptides, indicating the 
ability of tachyplesin I to bind to phospholipids. 
Maxima at 285 and 292 nm in the difference spec- 
tra could be ascribed to perturbation of both 
tyrosyl and tryptophanyl residues, respectively. 
Tachyplesin I contains two tyrosyl residues at the 
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Fig.3. Ultraviolet difference spectra of synthetic tachyplesin I
when titrated with increasing concentration of LPC at pH 8.0 
(0.02 M Tris-HCl containing 0.1 M NaCl). Synthetic 
tachyplesin I, 8.9 x 10m5 M: LPC concentrations (in mM) (a) 
0.17, (b) 0.34, (c) 0.51, (d) 0.67, (e) 0.84, (f) 0.99, (g) 1.15, (h) 
1.30, (j) 1.45, (k) 1.59, (1) 1.88, (m) 2.15 mM. Magnitudes of 
difference spectra were expressed by the difference molar 
absorption coefficient (AC). 
positions 8 and 13, one or both of which could be 
responsible for producing the characteristic spec- 
trum. On the other hand, we observed that only 
the tyrosyl residue(s) showed a minor degree of 
perturbation when tachyplesin I was titrated with 
(GlcNAcb (not shown). The results obtained sug- 
gest that tachyplesin I binds to LPS in the lipid 
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